Product Images Bupivacaine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Bupivacaine Hydrochloride NDC 55150-250 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.25% 125 mg per 50 mL (2.5 mg/mL) - 50 mL Container Label - bupivacaine fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.25% 125 mg per 50 mL (2.5 mg/mL) - 50 mL Container Label - bupivacaine fig1

A2 AUROMEDICS Bupivacaine HCI Injection USP is a medicine that comes in a 50 mL multiple dose vial. Each mL of the injection contains 2.5 mg bupivacaine hydrochloride USP along with methylparaben to keep it sterile. The injection is not meant for caudal, epidural, or spinal anesthesia. It should be stored at 20° to 25°C and can be used as per the instructions given in the package insert.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.25% 125 mg per 50 mL (2.5 mg/mL) - Container-Carton Label [25 Vials] - bupivacaine fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.25% 125 mg per 50 mL (2.5 mg/mL) - Container-Carton Label [25 Vials] - bupivacaine fig2

This is a medication called A2 AUROMEDICS, which contains 125 mg of Wi cupivacaine in a 50 mL solution (2.5 mg/mL). It is intended for infiltration and nerve block, but not for caudal, epidural, or spinal anesthesia. Each mL of the medication also contains 2.5 mg of bupivacaine hydrochloride USP, 1 mg of methylparaben as a preservative, and sodium chloride to make isotonic. It is a prescription medication and should be stored at 20° to 25°C. The medication comes in nonpyrogenic multiple dose vials, each containing 25 x 50 mL. It is distributed by AuroMedics Pharma LLC, which is based in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5% 250 mg per 50 mL (5 mg/mL) - 50 mL Container Label - bupivacaine fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5% 250 mg per 50 mL (5 mg/mL) - 50 mL Container Label - bupivacaine fig3

This is a description of a 5 mg/mL Bupivacaine Hydrochloride Injection with 250 mg per 50 mL (5mg/mL) in a 50 mL Multiple Dose Vial, for single-dose use only, and not for caudal, epidural, or spinal anesthesia. It contains 1 mg of methylparaben as preservative and sodium chloride to make isotonic in Water for Injection. The pH is adjusted with sodium hydroxide or hydrochloric acid. This injection is sterile and nonpyrogenic. It is manufactured by AuroMedics Pharma LLC in India and distributed in the United States at Princeton-Hightstown Road. The recommended storage temperature of the injection is between 20°C to 25°C. The package insert should be referred to for usual dosage.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5% 250 mg per 50 mL (5 mg/mL) - Container-Carton Label [25 Vials] - bupivacaine fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 0.5% 250 mg per 50 mL (5 mg/mL) - Container-Carton Label [25 Vials] - bupivacaine fig4

A2 Auromedics is a multiple dose vial of 50mL containing 250mg of Bupivacaine hydrochloride USP with 1mg of methylparaben as preservative and sodium chloride in water for injection which is used for nerve block. The usual dosage should be seen in the package insert. It should not be used for caudal, epidural, or spinal anesthesia. The vial stoppers are not made with natural rubber latex. It should be stored at 20-25°C. The details of the manufacturer are AuroMedics Pharma LLC and it is distributed by them in India.*

Bupivacaine Hydrochloride Chemical Structure - bupivacaine str

Bupivacaine Hydrochloride Chemical Structure - bupivacaine str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.